Biologic medicines have transformed modern healthcare, but their high cost continues to limit access for many patients worldwide. Biosimilars - biologic therapies shown to be highly similar to existing reference products - offer a powerful solution by introducing competition and reducing drug prices. Their adoption is already reshaping treatment landscapes, with proven cost savings and expanded patient access in key therapeutic areas. As regulatory frameworks evolve, biosimilars are positioned
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Weave Bio Raises $20M to Scale AI-Native Regulatory Automation Platform
What You Should Know:
- Weave Bio, a pioneer in AI-native regulatory automation management solutions announced it has raised $20M in Series A funding, bringing the company’s total capital raised to $36M led by USVP, with participation from Innovation Endeavors, Magnetic Ventures, Character, TMV, and Serrado Capital.
- The investment is set to accelerate the company’s mission to transform how novel therapies navigate the complex path from the lab to the global market.
Transforming
Read More
Caravel Bio Wins $7.8M NSF Grant to Pioneer Next-Generation Protein Engineering
What You Should Know:
- Caravel Bio, the first joint platform for protein discovery and delivery that enables new applications of synthetic biology, today announces its selection for a $7.8M award from the U.S. National Science Foundation Directorate for Technology, Innovation and Partnerships (NSF TIP).
- The award assembles a team of world-class engineers to create tools for building proteins with novel chemistries, train more advanced machine learning models on the resulting datasets,
Read More
Future Ready Pharma: Why Salesforce Life Sciences Cloud Redefines CRM
The life sciences industry is at a structural turning point. Engagement has expanded far beyond physicians to include payers, policymakers, care teams, and patient advocacy organizations. To remain competitive, organizations must orchestrate compliant, multistakeholder interactions while simultaneously accelerating product launches, breaking down internal silos, and delivering personalization at scale.
Against this backdrop, Salesforce’s Life Sciences Cloud (LSC) represents more than just a
Read More
Microplastics Are in Our Blood—Why Aren’t Federal Regulators Acting?
Microplastics are highly prevalent in the United States, contaminating various environmental compartments and even entering the human body. Studies have found microplastics in food, water, and air, with estimates suggesting that the average American consumes thousands to hundreds of thousands of microplastic particles annually (Ocean Conservatory). So it’s no surprise that the medical industry is stepping in and beginning to offer solutions and treatments to rid our body of these harmful toxins
Read More
The Science of Biophotons: Illuminating Health and Healing in Modern Medicine
For millennia, light has symbolized vitality and healing across cultures and religions. Ancient traditions, from Ayurveda’s prana to the radiant halos in Christian iconography, often depicted light as a marker of health or a conduit for restoration. These esoteric beliefs, though profound, lacked empirical grounding until modern science began to explore the phenomenon of light within living systems.
Today, the study of biophotons, defined as ultra-weak photon emissions from living
Read More
Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs
What You Should Know:
- Pfizer Inc. has announced a historic agreement with the Trump Administration that is designed to ensure U.S. patients pay lower prices for their prescription medicines while strengthening America’s role as the global leader in biopharmaceutical innovation.
- The voluntary agreement, made in response to a presidential letter, aims to implement measures that ensure Americans receive drug prices comparable to those available in other developed
Read More
Sanofi Commits Additional $625M to Sanofi Ventures to Fuel Biotech and Digital Health Innovation
What You Should Know:
- Sanofi Ventures has announced a significant $625M multi-year capital commitment from Sanofi, substantially increasing its total assets under management (AUM) to over $1.4B.
- The new capital injection into the evergreen venture fund reinforces Sanofi's strong belief that important medical breakthroughs often begin in early-stage companies.
Fueling Strategic Growth in Key Therapeutic Areas
The new funding commitment builds on more than a decade of
Read More
Beyond the “Batch of One”: How Flexible Manufacturing is Revolutionizing Biopharma
Biopharmaceutical companies today are facing a very different manufacturing challenge than they were a decade ago. Traditional production models were built to make large volumes of a small number of products. But with the rise of targeted therapies, faster development cycles, and increasing demand for personalized medicine, that one-size-fits-all approach no longer works.
Now, the industry is under pressure to support smaller batches, more complex processes, and tighter timelines—without
Read More
Ryght AI’s Clinical Research Platform Now Available on Microsoft Azure Marketplace
What You Should Know:
- Ryght AI today announced that its innovative clinical research platform is now available on Microsoft Azure Marketplace, providing sponsors and contract research organizations (CROs) with streamlined access to AI-powered site selection and feasibility workflows.
- This availability enables healthcare organizations to leverage their existing Microsoft Azure cloud commitments while accelerating clinical trial processes through advanced generative and agentic AI
Read More
